Literature DB >> 2372274

Ranitidine-associated recurrent acute pancreatitis.

R Herrmann1, R G Shaw, D J Fone.   

Abstract

Ranitidine is a safe, widely prescribed drug for the treatment of peptic ulcer disease and is rarely associated with serious adverse reactions. This report describes a patient who suffered three episodes of acute pancreatitis associated with ranitidine prescribed for duodenal ulcer disease. On each occasion the pancreatitis resolved after withdrawal of ranitidine and recurred upon re-exposure. Underlying biliary and pancreatic disease was excluded. There has been no recurrence of pancreatitis in the five years of follow-up since ranitidine was discontinued.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372274     DOI: 10.1111/j.1445-5994.1990.tb01028.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  5 in total

1.  The risk of acute pancreatitis associated with acid-suppressing drugs.

Authors:  I A Eland; C H Alvarez; B H Stricker; L A Rodríguez
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

Review 2.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 3.  A comparative overview of the adverse effects of antiulcer drugs.

Authors:  D W Piper
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

4.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

5.  Pancreatitis as a rare manifestation of Behçet disease.

Authors:  Matthew Hum; Muhammad N Mahmood; Vivian Huang; Marlene Dytoc
Journal:  JAAD Case Rep       Date:  2017-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.